文献速递瓣膜病与结构性心脏病

症状性主动脉瓣狭窄患者心脏损伤分期研究

Staging Cardiac Damage in Patients With Symptomatic Aortic Valve Stenosis.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

该研究在1189例症状性重度主动脉瓣狭窄患者中评估了一种基于心脏损伤范围的新分期系统的分布与预后影响。结果显示8%为0期、24%为1期、49%为2期、7%为3期、12%为4期,多变量分析中心脏损伤分期与全因死亡和复合终点独立相关,但主要由3期和4期驱动。

要点

  • 症状性重度AS患者中约半数处于2期(二尖瓣或左房损伤)。
  • 心脏损伤分期与全因死亡及复合终点独立相关。
  • 预后关联主要由3期(三尖瓣或肺动脉血管损伤)和4期(右室损伤)驱动。

核心结论

  • 在症状性重度主动脉瓣狭窄患者中,基于心脏损伤范围的新分期系统与全因死亡和复合终点独立相关。
  • 该预后关联似乎主要由3期(三尖瓣或肺动脉血管损伤)和4期(右心室功能障碍)驱动。

研究设计与样本

  • 来自2个学术机构正在进行的注册研究,共选取1189例症状性重度主动脉瓣狭窄患者进行回顾性分析。
  • 根据超声心动图所示心脏损伤范围,将患者分为0期(无心脏损伤)、1期(左心室损伤)、2期(二尖瓣或左心房损伤)、3期(三尖瓣或肺动脉血管损伤)或4期(右心室损伤)。
  • 随访全因死亡和复合终点(全因死亡、卒中和心脏相关住院)。

主要发现

  • 基于所提出的分类,8%的患者为0期,24%为1期,49%为2期,7%为3期,12%为4期。
  • 多变量分析中,心脏损伤与全因死亡和复合结局独立相关,但这主要由3期和4期决定。

临床怎么用

  • 对症状性重度AS患者,可采用该分期系统评估心脏损伤范围以辅助风险分层。
  • 尤其关注3期(三尖瓣或肺动脉血管损伤)和4期(右心室损伤)患者,因其预后关联更强。

局限性

  • 回顾性分析来自2个学术机构的注册研究。
  • 原文摘要未报告随访时长、具体效应值及置信区间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In severe aortic stenosis (AS), patients often show extra-aortic valvular injury. Recently, a new staging system for severe AS has been proposed on the basis of the extent of cardiac damage. OBJECTIVES: The present study evaluated the prevalence and prognostic impact of these different stages of cardiac damage in a large, real-world, multicenter cohort of symptomatic severe AS patients. METHODS: From the ongoing registries from 2 academic institutions, a total of 1,189 symptomatic severe AS patients were selected and retrospectively analyzed. According to the extent of cardiac damage on echocardiography, patients were classified as Stage 0 (no cardiac damage), Stage 1 (left ventricular damage), Stage 2 (mitral valve or left atrial damage), Stage 3 (tricuspid valve or pulmonary artery vasculature damage), or Stage 4 (right ventricular damage). Patients were followed for all-cause mortality and combined endpoint (all-cause mortality, stroke, and cardiac-related hospitalization). RESULTS: On the basis of the proposed classification, 8% of patients were classified as Stage 0, 24% as Stage 1, 49% as Stage 2, 7% as Stage 3, and 12% as Stage 4. On multivariable analysis, cardiac damage was independently associated with all-cause mortality and combined outcome, although this was mainly determined by Stages 3 and 4. CONCLUSIONS: In this large multicenter cohort of symptomatic severe AS patients, stage of cardiac injury as classified by a novel staging system was independently associated with all-cause mortality and combined endpoint, although this seemed to be predominantly driven by tricuspid valve or pulmonary artery vasculature damage (Stage 3) and right ventricular dysfunction (Stage 4).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Vollema EM, Amanullah MR, Ng ACT, et al. Staging Cardiac Damage in Patients With Symptomatic Aortic Valve Stenosis. J Am Coll Cardiol. 2019. PMID: 31345429. doi:10.1016/j.jacc.2019.05.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。